[关于预防和治疗中枢神经系统疾病的研究进展]
Qian Zhang1, Guang-Cheng Zhong1, Shu-Ting Li1
1Science and Technology Innovation Center, Guangzhou University of Chinese Medicine Guangzhou 510405, China.
概括
奥斯特霍尔 (OST) 在预防和治疗中枢神经系统 (CNS) 疾病方面表现有前途. 这种天然化合物表现出神经保护作用,为对抗中枢神经系统疾病的新治疗策略提供了潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 自然产品 化学 化学
背景情况:
- 中枢神经系统 (CNS) 疾病越来越普遍,严重影响患者的生活质量,并产生巨大的社会经济成本.
- 人口老龄化和生活水平的提高导致中枢神经系统疾病的发病率上升,需要新的治疗干预措施.
- 奥斯特霍尔 (OST) 是来自乌姆贝利属植物的天然化合物,具有多种药理活性,包括神经保护,抗氧化和抗炎性质.
研究的目的:
- 在各种中枢神经系统 (CNS) 疾病模型中系统地审查奥斯特霍尔 (OST) 预防和治疗作用的研究进展.
- 巩固证据支持OST作为中枢神经系统疾病治疗剂的潜力.
- 为OST在管理中枢神经系统疾病中的未来临床应用提供理论支持.
主要方法:
- 对国内和国际研究进行系统的文献综述.
- 对研究Osthole对中枢神经系统疾病模型的药理学影响的研究分析.
- 关于OST在预防和治疗中枢神经系统疾病方面的疗效的综合证据.
主要成果:
- 奥斯托尔 (OST) 在多种中枢神经系统疾病模型中表现出显著的预防和治疗效果.
- 有证据支持OST对中枢神经系统健康相关的神经保护,抗氧化和抗炎作用.
- OST的多方面的药理学特征表明它在中枢神经系统疾病管理中具有广泛的适用性.
结论:
- 奥斯托尔 (OST) 是一种有前途的天然化合物,用于预防和治疗中枢神经系统 (CNS) 疾病.
- 对OST的作用机制和临床疗效的进一步研究是有必要的.
- 在管理一系列中枢神经系统疾病方面,OST具有未来临床翻译的潜力.
相关概念视频
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
Neurotransmitters
839
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
839
Drugs Affecting Neurotransmitter Release or Uptake
994
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
994
Centrally Acting Muscle Relaxants: Therapeutic Uses
644
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
644


